Metformin vs Tolvaptan for Treatment of Autosomal Dominant Polycystic Kidney Disease
Condition: ADPKD Interventions: Drug: Metformin; Drug: Tolvaptan Sponsor: Azienda Ospedaliero-Universitaria Consorziale Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials